APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Enabling wireless monitoring In ambulances and homes
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
To enable company to be future-ready by tapping potential in CDMO space
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
Subscribe To Our Newsletter & Stay Updated
